Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.74 USD | -2.35% | -1.57% | +598.32% |
05-14 | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
05-02 | Elevation Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+598.32% | 209M | |
+8.76% | 115B | |
+9.77% | 105B | |
-13.12% | 22.71B | |
+2.21% | 21.83B | |
-10.88% | 18.18B | |
-41.90% | 16.52B | |
-16.09% | 16.01B | |
+1.00% | 14.14B | |
+17.99% | 10.71B |
- Stock Market
- Equities
- ELEV Stock
- News Elevation Oncology, Inc.
- Elevation Oncology Appoints David Dornan as Chief Scientific Officer